Not Medicare Enrolled
Dr. Mohammad Jahanzeb, MD
Hematology & Oncology · Boca Raton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jahanzeb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jahanzeb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jahanzeb
Dr. Mohammad Jahanzeb is a hematology & oncology specialist in Boca Raton, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Jahanzeb performed 10,010 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jahanzeb received a total of $1,149,422 from 84 pharmaceutical and/or device companies across 1302 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jahanzeb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 26% volume in FL
$1,149,422 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗10,010
Medicare services
Top 26% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (aprepitant) | 4,680 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,660 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
490 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 360 | $1 | $28 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
174 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
135 | $8 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
100 | $12 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $100 | $339 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
74 | $21 | $84 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
72 | $101 | $378 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
67 | $11 | $69 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
30 | $1 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $67 | $239 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
16 | $46 | $189 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $111 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.6% high complexity
93.8% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,149,422
Total received (2018-2024)
Avg $164,203/year across 7 years
Top 1% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,302
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$316,575
2023
$220,840
2022
$250,505
2021
$111,873
2020
$85,510
2019
$85,565
2018
$78,554
Payments by company (2024)
Takeda Pharmaceuticals U.S.A., Inc.
$98,917
Regeneron Healthcare Solutions, Inc.
$85,319
AstraZeneca Pharmaceuticals LP
$50,897
Daiichi Sankyo Inc.
$35,649
Bard Peripheral Vascular, Inc.
$26,000
Novocure Inc.
$12,875
Merck Sharp & Dohme LLC
$6,434
E.R. Squibb & Sons, L.L.C.
$305
Coherus Biosciences Inc.
$93
Stemline Therapeutics Inc.
$45
Janssen Biotech, Inc.
$41
Top 3 companies account for 74.3% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$308,383
AstraZeneca Pharmaceuticals LP
$210,597
Daiichi Sankyo Inc.
$121,945
Regeneron Healthcare Solutions, Inc.
$106,286
Merck Sharp & Dohme LLC
$68,948
Gilead Sciences, Inc.
$65,653
Merck Sharp & Dohme Corporation
$45,421
Takeda Pharmaceuticals International, Inc.
$31,553
Bard Peripheral Vascular, Inc.
$26,047
Novocure Inc.
$25,429
Novartis Pharmaceuticals Corporation
$22,859
Stemline Therapeutics Inc.
$17,882
PFIZER INC.
$17,424
Mirati Therapeutics, Inc.
$13,624
F. Hoffmann-La Roche AG
$11,352
PUMA BIOTECHNOLOGY, INC.
$8,734
Amgen Inc.
$8,627
AbbVie, Inc.
$6,100
Genentech USA, Inc.
$5,164
PFIZER INTERNATIONAL LLC
$3,147
NOVARTIS PHARMACEUTICALS CORPORATION
$2,931
GENZYME CORPORATION
$2,751
Seagen Inc.
$2,683
ABBVIE INC.
$2,250
E.R. Squibb & Sons, L.L.C.
$1,603
Bayer HealthCare Pharmaceuticals Inc.
$1,327
Puma Biotechnology, Inc.
$1,277
Immunomedics, Inc.
$1,250
Boehringer Ingelheim Pharmaceuticals, Inc.
$963
Sirtex Medical Inc
$951
Foundation Medicine, Inc.
$747
Coherus Biosciences Inc.
$618
Ipsen Bioscience Inc
$580
GlaxoSmithKline, LLC.
$343
AtriCure, Inc.
$287
Janssen Biotech, Inc.
$252
EMD Serono, Inc.
$244
Clovis Oncology, Inc.
$204
Pharmacyclics LLC, An AbbVie Company
$202
Lilly USA, LLC
$200
Celgene Corporation
$188
ATRICURE, INC.
$161
Heron Therapeutics, Inc.
$155
Incyte Corporation
$135
Roche Diagnostics Corporation
$132
Taiho Oncology, Inc.
$128
Exelixis Inc.
$125
JAZZ PHARMACEUTICALS INC.
$124
ARRAY BIOPHARMA INC
$122
TESARO, Inc.
$119
Blueprint Medicines Corporation
$92
Astellas Pharma US Inc
$77
Pharmacyclics LLC, an AbbVie Company
$74
Eisai Inc.
$72
BARD PERIPHERAL VASCULAR, INC.
$71
Kite Pharma, Inc.
$68
Ipsen Biopharmaceuticals, Inc
$54
TerSera Therapeutics LLC
$51
Deciphera Pharmaceuticals Inc.
$46
SERVIER PHARMACEUTICALS LLC
$42
Teva Pharmaceuticals USA, Inc.
$39
Medtronic, Inc.
$37
Octapharma USA, Inc.
$37
Mylan Institutional Inc.
$36
Advanced Accelerator Applications
$32
Seattle Genetics, Inc.
$29
EISAI INC.
$25
Blue Earth Diagnostics Limited
$24
PharmaEssentia USA Corporation
$24
Servier Pharmaceuticals LLC
$24
Emmaus Medical, Inc.
$22
Array BioPharma Inc.
$21
Kyowa Kirin, Inc.
$21
TOLMAR Pharmaceuticals, Inc.
$20
Partner Therapeutics, Inc.
$20
Jazz Pharmaceuticals Inc.
$19
G1 Therapeutics, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
Dova Pharmaceuticals
$17
GE HEALTHCARE
$15
Fortovia Therapeutics, Inc.
$15
Organon LLC
$13
MACROGENICS, INC.
$12
Secura Bio, Inc.
$11
Top 3 companies account for 55.8% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · ALIMTA · ALUNBRIG · ATACAND · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ERBITUX · EXKIVITY · Endari · Enhertu · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID · Farydak · Fulphila · GAVRETO · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LEUKINE · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Non-Covered · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONTRUZANT · OPDIVO · OPTUNE LUA (NOVOTTF-200T) · OSTEOCOOL RF ABLATION SYSTEM · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONVENDI · Vectibix · Venclexta · XALKORI · XGEVA · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
78
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BOCA RATON REGIONAL HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jahanzeb is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jahanzeb experienced with anti-nausea injection (aprepitant)?
Based on Medicare claims data, Dr. Jahanzeb performed 4,680 anti-nausea injection (aprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jahanzeb receive payments from pharmaceutical companies?
Yes. Dr. Jahanzeb received a total of $1,149,422 from 84 companies across 1,302 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jahanzeb's costs compare to other hematology & oncology specialists in Boca Raton?
Dr. Jahanzeb's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jahanzeb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Boca Raton
Browse hematology & oncology specialists in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology